SEC Info - Cooper John G - ‘4’ for 11/7/02 re: Windtree Therapeutics Inc./DE

SEC Info℠

Home

Help

Please Sign In

Cooper John G – ‘4’ for 11/7/02 re: Windtree Therapeutics Inc./DE

On: Tuesday, 11/12/02, at 4:58pm ET · For: 11/7/02 · Accession #: 1169232-2-2689 · File #: 0-26422

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/12/02  Cooper John G                     4          Officer     1:11K  Discovery Laboratories Inc./DE    Edgar Ease Svc Bureau/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of        4±    17K 
                Securities by an Insider                                         

4 1st “Page” of 2 TOC ↑Top Previous Next ↓Bottom Just 1st
 
                                                  ------------------------------
                                                OMB APPROVAL
                                                  ------------------------------
                                                  OMB Number:          3235-0287
                                                  Expires:      January 31, 2005
                                            Estimated average burden
                                                  hours per response.........0.5
                                                  ------------------------------

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, 
Section 17(a) of the Public Utility Holding Company Act of 1935 or
 Section 30(h) of the Investment Company Act of 1940

|_|  Check this box if no longer subject to Section 16. Form 4 or Form 5        
obligations may continue. See Instruction 1(b).                       

(Print of Type Responses)                                                       
________________________________________________________________________________
1.   Name and Address of Reporting Person*                                      

Cooper,                        John                G.                 
--------------------------------------------------------------------------------
(Last)                           (First)             (Middle)             

22 Zinnia Dr.                                                         
--------------------------------------------------------------------------------
(Street)

Newtown                        PA                   18940             
--------------------------------------------------------------------------------
(City)                           (State)              (Zip)               

________________________________________________________________________________
2.   Issuer Name and Ticker or Trading Symbol                                   

Discovery Laboratories, Inc. (Discovery)                              
DSCO                                                                  
________________________________________________________________________________
3.   I.R.S. Identification Number of Reporting Person, if an entity (voluntary) 

________________________________________________________________________________
4.   Statement for Month/Day/Year                                               

November 7, 2002                                                      
________________________________________________________________________________
5.   If Amendment, Date of Original (Month/Day/Year)                            

________________________________________________________________________________
6.   Relationship of Reporting Person(s) to Issuer                              
(Check all applicable)                                                

|_|  Director                             |_|  10% Owner              
|X|  Officer (give title below)           |_|  Other (specify below)  

Senior Vice President, Chief Financial Officer                        
____________________________________________________________________  
________________________________________________________________________________
7.   Individual or Joint/Group Filing (Check Applicable line)                   

|X|  Form Filed by One Reporting Person                               
|_|  Form Filed by More than One Reporting Person                     
________________________________________________________________________________

================================================================================
 Table I -- Non-Derivative Securities Acquired, Disposed of,
or Beneficially Owned 
================================================================================

                                                        [Enlarge/Download Table]

                                                                                                 5.                                 
                                                                                                 Amount of      6.                  
                                                                 4.                              Securities     Owner-              
                                                                 Securities Acquired (A) or      Beneficially   ship                
                                       2A.          3.           Disposed of (D)                 Owned          Form:     7.        
                            2.         Deemed       Transaction  (Instr. 3, 4 and 5)             Following      Direct    Nature of 
                            Trans-     Execution    Code         ------------------------------- Reported       (D) or    Indirect  
1.                          action     Date, if     (Instr. 8)                   (A)             Transaction(s) Indirect  Beneficial
Title of Security           Date       any          ------------                 or              (Instr. 3 &    (I)       Ownership 
(Instr. 3)                  (mm/dd/yy) (mm/dd/yy)    Code     V      Amount      (D)    Price     Instr.4)      (Instr.4) (Instr.4) 
------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                                    

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

====================================================================================================================================

Reminder: Report on a separate line for each class of securities beneficially   
owned directly or indirectly.                                                   

*     If the form is filed by more than one reporting person, see Instruction   
4(b)(v).                                                            

  Persons who respond to the collection of information contained in this
 form are not required to respond unless the form displays a currently
valid OMB control number                                            

4 Last “Page” of 2 TOC 1st Previous Next ↓Bottom Just 2nd
FORM 4 (continued)                                                              

Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned  
      (e.g., puts, calls, warrants, options, convertible securities)

================================================================================

                                                        [Enlarge/Download Table]

                                                                                                          9.                        
                                                                                                          Number    10.             
                                                                                                          of        Owner-          
                                                                                                          deriv-    ship            
                                                                                                          ative     Form            
             2.                                                                                           Secur-    of              
             Conver-                            5.                              7.                        ities     Deriv-   11.    
             sion                               Number of                       Title and Amount          Bene-     ative    Nature 
             or                                 Derivative    6.                of Underlying     8.      ficially  Secur-   of     
             Exer-            3A.      4.       Securities    Date              Securities        Price   Owned     ity:     In-    
             cise             Deemed   Trans-   Acquired (A)  Exercisable and   (Instr. 3 and 4)  of      Follow-   Direct   direct 
             Price   3.       Execut-  action   or Disposed   Expiration Date   ----------------  Deriv-  ing       (D) or   Bene-  
1.           of      Trans-   ion      Code     of(D)         (Month/Day/Year)            Amount  ative   Reported  In-      ficial 
Title of     Deriv-  action   Date if  (Instr.  (Instr. 3,    ----------------            or      Secur-  Trans-    direct   Owner- 
Derivative   ative   Date     any      8)       4 and 5)      Date       Expira-          Number  ity     action(s) (I)      ship   
Security     Secur-  (mm/dd/  (mm/dd/  ------   ------------  Exer-      tion             of      (Instr. (Instr.   (Instr.  (Instr.
(Instr. 3)   ity     yy)      yy)      Code V    (A)   (D)    cisable    Date    Title    Shares  5)      4)        4)       4)     
------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                                    
Employee     $1.94   11/5/02           A         A            11/5/02(1) 11/4/12  Common   30,000  $1.94   235,000   D              
Stock                                                                             Stock                                             
Options                                                                                                                             
------------------------------------------------------------------------------------------------------------------------------------
Employee     $1.72   6/27/02           A    V    A            6/27/02(1) 6/26/12  Common  105,000  $1.72   235,000   D              
Stock                                                                             Stock                                             
Options                                                                                                                             
------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------------------------

====================================================================================================================================

Explanation of Responses:                                                       

(1) This employee stock option is immediately exercisable and vests 25% on the  
date of the grant. The remaining 75% of the option shares become vested in three
equal annual installments beginning with the first year anniversary of the      
grant.                                                                          

   /s/ John G. Cooper                                   11/12/02
---------------------------------------------            -----------------------
**Signature of Reporting Person                             Date    

**     Intentional misstatements or omissions of facts constitute Federal       
Criminal Violations.                                              

See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).                         

Note:  File three copies of this Form, one of which must be manually signed.    
If space is insufficient, see Instruction 6 for procedure.        

                                                                          Page 2

4	1st “Page” of 2	TOC	↑Top	Previous	Next	↓Bottom	Just 1st

4	Last “Page” of 2	TOC	1st	Previous	Next	↓Bottom	Just 2nd

Dates Referenced Herein and Documents Incorporated by Reference

		Referenced-On Page
This ‘4’ Filing	Date	First	Last	Other Filings

	1/31/05	1
Filed on:	11/12/02			4, 8-K
For Period end:	11/7/02	1		4
				List all Filings

↑Top

Filing Submission 0001169232-02-002689 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Cooper John G – ‘4’ for 11/7/02 re: Windtree Therapeutics Inc./DE

On: Tuesday, 11/12/02, at 4:58pm ET · For: 11/7/02 · Accession #: 1169232-2-2689 · File #: 0-26422

Previous ‘4’: ‘4’ on 7/19/02 for 7/1/02 · Next: ‘4’ on 7/16/03 for 12/13/02 · Latest: ‘4’ on 5/25/23 for 5/23/23

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34Filing Table of Contents

Dates Referenced Herein and Documents Incorporated by Reference

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34
Filing Table of Contents